Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Tg Therapeutics (TGTX) recorded Return on Capital Employed [ROCE] of 10.36% in Q2 2026, down 6.55 percentage points from 16.91% a year earlier and down 3.12 percentage points from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Tg Therapeutics reported Return on Capital Employed [ROCE] of 18.50%, up 6.95 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three straight years, with a five-year change of +107.68 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 11.55% in FY2024 (+1.63 pp), 9.93% in FY2023 (+103.46 pp), -93.54% in FY2022 (-14.69 pp) and -78.85% in FY2021 (+10.33 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in five of the last eight quarters, with an average year-over-year change of +1.17 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 178.87 percentage points in Q2 2024, against a drop of 49.29 percentage points in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 13.48% (Q1 2026), 13.85% (Q4 2025) and 14.54% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn 14.23%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.23%
Jun 30, 2026 10.36%
Mar 31, 2026 13.48%
Dec 31, 2025 13.85%
Sep 30, 2025 14.54%
Jun 30, 2025 16.91%
Mar 31, 2025 13.09%
Dec 31, 2024 8.54%
Sep 30, 2024 -0.14%
Jun 30, 2024 36.56%
Mar 31, 2024 19.21%
Dec 31, 2023 7.46%
Sep 30, 2023 -20.35%
Jun 30, 2023 -142.31%
Mar 31, 2023 -142.33%
Dec 31, 2022 -143.13%
Sep 30, 2022 -117.84%
Jun 30, 2022 -121.31%
Mar 31, 2022 -112.48%
Dec 31, 2021 -104.71%
API Access

Tg Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TGTX&period=max&api_key=YOUR_API_KEY